Never miss an issue of Master Investor Magazine – sign-up now for free!
AIM-listed aquaculture specialist Benchmark Holdings (LON:BMK) has announced that revenues for the year ended 30th September rose by 7% to more than £150 million, as both the genetics and advanced health divisions saw rising sales.
Chief executive Malcolm Pye said: “We performed well during the year. We have delivered revenue and profit growth, while undertaking significant strategic projects that have enhanced our position in our key markets and provide a strengthened platform for the future.
“This together with the continued progress in our pipeline and corporate structure leaves us well placed to address the significant opportunities in our markets, which have stronger drivers than ever before amid increasing recognition from consumers, producers and regulators of the need for sustainable aquaculture solutions“.
Benchmark’s share price sank by 2.48% to 59p (as of 14:15 GMT).